Efficacy and safety of bevacizumab with standard first-line fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer: First beat

被引：0
|
作者：
Rivera, F.
Cunningham, D. [1 ]
Berry, S. [2 ]
Kretzschmar, A. [3 ]
Michael, M. [4 ]
Dibartolomeo, M. [5 ]
Mazier, M. [6 ]
Andre, N. [7 ]
Van Cutsem, E. [8 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Sutton, Surrey, England
[2] Sunnybrook Hlth Sci Ctr, Div Haematol Med Oncol, Toronto, ON M4N 3M5, Canada
[3] HELIOS Klin, Robert Rossle Klin, Charite, Berlin, Germany
[4] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
[5] Ist Nazl Tumori, Div Med Oncol, Unit 2, I-20133 Milan, Italy
[6] Paraxel, Dept Stat, Paris, France
[7] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[8] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study
    Francois, Eric
    Mineur, Laurent
    Deplanque, Gael
    Laplaige, Philippe
    Smith, Denis
    Gourgou, Sophie
    Tanang, Alexandre
    Ionescu-Goga, Miruna
    Veerabudun, Kalaivani
    Lelarge, Yoann
    Kim, Stefano
    Rollot, Florence
    [J]. CLINICAL COLORECTAL CANCER, 2020, 19 (03) : E100 - E109
  • [32] Microsatellite instability and sensitivity to fluoropyrimidine and oxaliplatin containing first-line chemotherapy in metastatic colorectal cancer
    Liu, Jia
    Wang, Biao
    Fang, Wentong
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (05) : 267 - 270
  • [33] Should FOLFOXIRI Plus Bevacizumab Be the Standard First-Line Therapy in Metastatic Colorectal Cancer?
    Nipp, Ryan D.
    Ryan, David P.
    [J]. ONCOLOGIST, 2015, 20 (03): : 236 - 238
  • [34] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    [J]. MEDICINE, 2016, 95 (51) : e4531
  • [35] FOLFIRI® and Bevacizumab in first-line treatment for colorectal cancer patients: Safety, efficacy and genetic polymorphisms
    Bécouarn Y.
    Cany L.
    Pulido M.
    Beyssac R.
    Texereau P.
    Le Morvan V.
    Béchade D.
    Brunet R.
    Aitouferoukh S.
    Lalet C.
    Mathoulin-Pélissier S.
    Fonck M.
    Robert J.
    [J]. BMC Research Notes, 7 (1)
  • [36] Bevacizumab with chemotherapy for the first-line treatment of metastatic colorectal cancer: "NCI Slovakia" results
    Dolinsky, J.
    Salek, T.
    Hlavata, Z.
    Ivancova, H.
    Risnyovszka, Z.
    Mardiak, J.
    Koza, I
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 70 - 70
  • [37] Bevacizumab in combination with chemotherapy in the first-line treatment of metastatic colorectal carcinoma
    Usakova, V.
    Sevcikova, K.
    Usak, J.
    Bartosova, Z.
    Mikulova, M.
    Spanik, S.
    [J]. NEOPLASMA, 2013, 60 (01) : 83 - 91
  • [38] Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience
    Salek, T.
    Mego, M.
    Mardiak, J.
    Andrasina, I.
    Spanik, S.
    Malec, V.
    Barilla, R.
    Riedelova, K.
    Benedikty, A.
    Dammak, A.
    Porsok, S.
    Svabova, V.
    Chovanec, M.
    Cipkova, A.
    Usakova, V.
    Siskova, M.
    Jurisova, S.
    Dolinsky, J.
    Hlavata, Z.
    Andrezalova, I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-Study.
    Hochster, H. S.
    Hart, L. L.
    Ramanathan, R. K.
    Hainsworth, J. D.
    Hedrick, E. E.
    Childs, B. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 148S - 148S
  • [40] Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer
    Cazeneuve, Nicolas
    Bouche, Olivier
    Leger, Julie
    Borg, Christophe
    Labbe-Devilliers, Catherine
    Lucidarme, Olivier
    Tasu, Jean-Pierre
    Manfredi, Sylvain
    Aube, Christophe
    Trillaud, Herve
    Manzoni, Philippe
    Marcus, Claude
    Terrebonne, Eric
    Douillard, Jean -Yves
    Chautard, Romain
    Lobet, Sarah
    Bleuzen, Aurore
    Lecomte, Thierry
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
12345